Self-collection for under-screened women in a National Cervical Screening Program: pilot study

被引:43
作者
Saville, M. [1 ,2 ]
Hawkes, D. [1 ,3 ]
Mclachlan, E. [4 ]
Anderson, S. [5 ]
Arabena, K. [4 ]
机构
[1] Victorian Cytol Serv, 265 Faraday St, Carlton, Vic 3053, Australia
[2] Univ Melbourne, Dept Obstet & Gynaecol, Parkville, Vic, Australia
[3] Univ Melbourne, Dept Pharmacol & Therapeut, Parkville, Vic, Australia
[4] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Indigenous Hlth Equ Unit, Parkville, Vic, Australia
[5] Baarlinjan Med Clin, Ballarat & Dist Aboriginal Collect, Ballarat, Vic, Australia
关键词
Human papillomavirus (HPV); self-collection; cervical cancer screening; diagnostic testing; HUMAN-PAPILLOMAVIRUS; AUSTRALIAN WOMEN; SAMPLES; VACCINATION; PREVALENCE; CANCER;
D O I
10.3747/co.25.3915
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Commencing 1 December 2017, Australia introduced human papillomavirus (HPV)-based cervical screening. As part of this Australian renewed National Cervical Screening Program (NCSP) women who are either never-or under-screened and who refuse a practitioner collected sample will be able to collect their own sample for cervical screening. The aim of this study is to examine the quantitative results of a pilot study into the acceptability of the self-collection alternative pathway. Methods Eligible participants were offered the opportunity to collect their own sample. Those who agreed were given a flocked swab and an instruction sheet and took their own sample in an area of the health care clinic that afforded them adequate privacy. These samples were then given to clinic staff who returned them to Victorian Cytology Service (VCS) Pathology for HPV nucleic acid testing. Results Of 98 eligible women, seventy-nine undertook self-collection for HPV-based cervical screening. Seventy-seven produced valid results, 14 were positive for oncogenic HPV, with 10 undertaking follow-up. Three women were found to have cervical squamous abnormalities with two of those being high-grade intraepithelial squamous lesions. Conclusion The pilot study for self-collection for cervical screening produced quantitative data that were similar to that already reported in the literature, but had a much higher rate of acceptance compared with self-collection programs based in the home.
引用
收藏
页码:E27 / E32
页数:6
相关论文
共 19 条
[1]  
(AIHW) AIoHaW, 2015, AIHW CANC SER
[2]   Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis [J].
Arbyn, Marc ;
Verdoodt, Freija ;
Snijders, Peter J. F. ;
Verhoef, Viola M. J. ;
Suonio, Eero ;
Dillner, Lena ;
Minozzi, Silvia ;
Bellisario, Cristina ;
Banzi, Rita ;
Zhao, Fang-Hui ;
Hillemanns, Peter ;
Anttila, Ahti .
LANCET ONCOLOGY, 2014, 15 (02) :172-183
[3]   Human papillomavirus vaccination and cervical cancer screening by socioeconomic status, Victoria [J].
Barbaro, Bianca ;
Brotherton, Julia M. L. ;
Gertig, Dorota M. .
MEDICAL JOURNAL OF AUSTRALIA, 2012, 196 (07) :445-445
[4]   Human papillomavirus prevalence to age 60 years among Australian women prevaccination [J].
Brotherton, Julia M. L. ;
Condon, John R. ;
McIntyre, Peter B. ;
Tabrizi, Sepehr N. ;
Malloy, Michael ;
Garland, Suzanne M. .
SEXUAL HEALTH, 2015, 12 (04) :353-359
[5]   Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial [J].
Canfell, Karen ;
Caruana, Michael ;
Gebski, Val ;
Darlington-Brown, Jessica ;
Heley, Stella ;
Brotherton, Julia ;
Gertig, Dorota ;
Jennett, Chloe J. ;
Farnsworth, Annabelle ;
Tan, Jeffrey ;
Wrede, C. David ;
Castle, Philip E. ;
Saville, Marion .
PLOS MEDICINE, 2017, 14 (09)
[6]   Performance of a Cartridge-Based Assay for Detection of Clinically Significant Human Papillomavirus (HPV) Infection: Lessons from VALGENT (Validation of HPV Genotyping Tests) [J].
Cuschieri, Kate ;
Geraets, Daan ;
Cuzick, Jack ;
Cadman, Louise ;
Moore, Catherine ;
Vanden Broeck, Davy ;
Padalko, Elisaveta ;
Quint, Wim ;
Arbyn, Marc .
JOURNAL OF CLINICAL MICROBIOLOGY, 2016, 54 (09) :2337-2342
[7]   Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study [J].
Dillner, Joalim ;
Rebolj, Matejka ;
Birembaut, Philippe ;
Petry, Karl-Ulrich ;
Szarewski, Anne ;
Munk, Christian ;
de Sanjose, Silvia ;
Naucler, Pontus ;
Lloveras, Belen ;
Kjaer, Susanne ;
Cuzick, Jack ;
van Ballegooijen, Marjolein ;
Clavel, Christine ;
Iftner, Thomas .
BRITISH MEDICAL JOURNAL, 2008, 337 (7676) :a1754
[8]  
Hawkes D, 2017, 31 INT PAP C CAP TOW
[9]   The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice [J].
Khan, MJ ;
Castle, PE ;
Lorincz, AT ;
Wacholder, S ;
Sherman, M ;
Scott, DR ;
Rush, BB ;
Glass, AG ;
Shiffman, M .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (14) :1072-1079
[10]   Prevalence of Human Papillomavirus in Self-Taken Samples from Screening Nonattenders [J].
Lam, J. U. H. ;
Rebolj, M. ;
Ejegod, D. M. ;
Pedersen, H. ;
Rygaard, C. ;
Lynge, E. ;
Harder, E. ;
Thomsen, L. T. ;
Kjaer, S. K. ;
Bonde, J. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2017, 55 (10) :2913-2923